A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Evaluate the Safety and Tolerability of Paliperidone ER and Olanzapine in Subjects with Schizophrenia

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-006967-22

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to show that paliperidone is superior to olanzapine in the improvement of the triglyceride to high density lipoprotein ratio (TG:HDL ratio)


Critère d'inclusion

  • Schizophrenia